Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Alumis Inc. ( (ALMS) ) is now available.
On January 7, 2026, Alumis Inc. entered into an underwriting agreement with a syndicate of banks led by Morgan Stanley, Leerink Partners and Cantor Fitzgerald to conduct a public offering of 17,650,000 shares of its voting common stock at $17.00 per share, with all shares sold by the company. The deal, made under an effective shelf registration, is expected to raise approximately $345.1 million in gross proceeds before expenses, with closing targeted for January 9, 2026, and includes a fully exercised 30-day option for underwriters to buy an additional 2,647,500 shares, underscoring a significant capital raise that could strengthen Alumis’s balance sheet and financial flexibility, subject to customary closing conditions and market risks disclosed in its SEC filings.
The most recent analyst rating on (ALMS) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Alumis Inc. stock, see the ALMS Stock Forecast page.
Spark’s Take on ALMS Stock
According to Spark, TipRanks’ AI Analyst, ALMS is a Neutral.
The score is primarily held back by heavy cash burn and deeply negative profitability despite emerging revenue and strong gross margin. Technicals are mixed with near-term weakness and oversold signals, while valuation is constrained by a negative P/E and no dividend support. Positive Phase 3 trial results provide an important upside catalyst, partially offset by a legal dispute risk.
To see Spark’s full report on ALMS stock, click here.
More about Alumis Inc.
Average Trading Volume: 2,337,194
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.87B
For a thorough assessment of ALMS stock, go to TipRanks’ Stock Analysis page.

